New Zealand - English - Medsafe (Medicines Safety Authority)

pharmabroker sales ltd - antibody to hcg hormone, murine monoclonal antibody to hcg - pregnancy test kit - 4.2µg, 3.2µg

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmabroker sales ltd - antibody to hcg hormone, murine monoclonal antibody to hcg - pregnancy test kit

Israel - English - Ministry of Health

merck serono ltd - luteinizing hormone - powder for solution for injection - luteinizing hormone 75 iu/ml - gonadotropins - luveris in association with a follicle stimulating hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.

European Union - English - EMA (European Medicines Agency)

merck europe b.v.  - lutropin alfa - ovulation induction; infertility, female - sex hormones and modulators of the genital system, - luveris in association with a follicle-stimulating-hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe luteinising-hormone (lh) and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh level

European Union - English - EMA (European Medicines Agency)

xbiotech germany gmbh - human igg1 monoclonal antibody specific for human interleukin-1 alpha - colorectal neoplasms - antineoplastic agents - treatment of metastatic colorectal cancer

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated infectious bursal disease (ibd) virus , infectious bursal disease (ibd) virus-specific antibody complexed vaccine (vet.) - lyophilized powder for injection (in-ovo/sc) - each 0.05 ml (in-ovo) or 0.2 ml (sc) (dose) contains: live attenuated infectious bursal disease virus (ibd) (1052 strain)-10^1.48 - 10^2.80* infectious bursal disease (ibd) virus-specific antibody-2.7x10^6 igy** *pu: polacy units **vnu: virus neutralization units

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 48446 - hiv1/hiv2 antigen/antibody ivd, kit, chemiluminescent immunoassay - the advia centaur chiv assay is a two-wash antigen/antibody sandwich immunoassay using direct chemiluminometric technology an in vitro diagnostic immunoassay intended to be used in testing clinical specimens for the detection of human immunodeficiency virus (hiv) p24 antigen and antibodies to human immunodeficiency virus type 1 (hiv-1), including group "o", and/or type 2 (hiv-2), to aid in the diagnosis of hiv infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 48446 - hiv1/hiv2 antigen/antibody ivd, kit, chemiluminescent immunoassay - atellica im chiv assay is a 2-wash antigen/antibody sandwich immunoassay in which antigens are bridged by antibody present in the patient sample and antigen (p24) in the sample is bridged by antibody present in the reagents. an in vitro diagnostic immunoassay for the simultaneous qualitative detection of human immunodeficiency virus p24 antigen and antibodies to human immunodeficiency viruses type 1 (including group "o") and type 2, in adult and paediatric serum and plasma (edta) to aid in the diagnosis of hiv infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd diagnostic division - 48304 - hepatitis b virus core total antibody ivd, kit, chemiluminescent immunoassay - a chemiluminescent microparticle assay for the qualitative determination of anti-hbc in clinical specimens. the architect anti-hbc ii assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of antibody to hepatitis b core antigen (anti-hbc) in human serum and plasma, including specimens collected post-mortem (non-heart beating) on the architect analyser. performance has been established for the use of cadaveric blood specimens (specimens collected post-mortem, non-heart beating) that have been collected up to 24 hours after death.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd diagnostic division - 48316 - hepatitis b virus surface total antibody ivd, kit, chemiluminescent immunoassay - the architect anti-hbs assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in clinical specimens. a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in clinical specimens.